Inductive Bio, Inc.
Last verified 2026-05-22. JSON
| Total raised | $25.1M |
|---|---|
| Latest round | Funding round, $25.1M, 2025-05-07 |
| Founded | unknown |
| Headquarters | BROOKLYN, NY |
| Industry | bio |
| Stage | unknown |
| Website | inductivebio.com |
Inductive Bio offers AI drug-discovery tools that run millions of virtual experiments to predict molecular behavior before synthesis. It serves biotechs and discovery teams at companies like Belharra and Arrakis. Its Beacon-1 ADMET models won the largest blind ADMET competitions in 2025 and 2026.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-05-07 | Funding round | $25.1M | undisclosed |
Detected tech stack
Cloudflare, Google Analytics, Google Tag Manager, jsDelivr, DoubleClick Floodlight, WordPress, PHP, MySQL, jquery 3.5.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $25.1M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $25.1M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | inductivebio.com, read 2026-05-22 |
| Description | self-reported | inductivebio.com, read 2026-05-22 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $25.1M, 2025-05-07 → Funding round, $25.1M, 2025-05-07, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $25.1M, 2025-05-07 → Funding round, $25.1M, 2025-05-07 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes